Iradimed (IRMD) Stock Statistics & Valuation Metrics

Iradimed has a market cap or net worth of $924.62M. The enterprise value is $714.43M.

Iradimed has 12,720,002 shares outstanding. The number of shares has decreased by -2.65% in one year.

Iradimed’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 19.31%.

The current PE Ratio of Iradimed is 44.3. Iradimed’s PEG ratio is ―.

In the last 12 months, Iradimed had revenue of 73.24M and earned 19.23M in profits. Earnings per share was 1.52.

In the last 12 months, operating cash flow was 27.14M and capital expenditures -13.59M, giving a free cash flow of 13.55M billion.

Iradimed pays an annual dividend of $0.17, resulting in a dividend yield of 0.89%

Iradimed upcoming earnings date is Oct 31, 2025, Before Open (Confirmed).

Iradimed as a current ratio of 8.84, with Debt / Equity ratio of 0.00%

In the past 12 months, Iradimed has paid 5.04M in taxes.

Iradimed EV to EBITDA ratio is 28.30, with an EV/FCF ratio of 36.59.

Iradimed has $53.00M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$53.00M billion.

Gross margin is 76.96%, with operating margin of 29.99%, and net profit margin of 26.26%.

The average price target for Iradimed is $74.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy